Drug Industry Takes Aim at 340B Program’s Growth in Pair of Op-Eds

PhRMA President and CEO Steve Ubl and Joe Grogan, a former Trump assistant and director of the White House’s Domestic Policy Council, took aim at the 340B program in a pair of recent op-eds.
The head of an influential drug industry trade group and a former Trump administration official recently called for federal 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Column: Setting the Record Straight on 340B Growth

Ted Slafsky, publisher and CEO of 340B Report, writes about HHS Secretary Robert F. Kennedy Jr.'s controversial views on the 340B program.
U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy Jr.’s eagerly anticipated first take on the 340B drug discount [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

HRSA Issues New Health Center 340B Requirements for Insulin, EpiPens Following Trump’s April Executive Order

HRSA issued new 340B-related grant terms for federally qualified health centers to implement an April 15 executive order on drug pricing.
The Health Resources and Services Administration (HRSA) on Tuesday rolled out new grant terms that require federally qualified health centers [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

RFK Jr. Touts HHS Budget Plan, PBM Reform & Drug Pricing Efforts; Rep. Harshbarger Suggests 340B Contract Changes

HHS Secretary Robert F. Kennedy Jr. testified before the U.S. House E&C Committee’s Health Subcommittee Tuesday on the president’s HHS budget.
Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. this week defended President Donald Trump’s Fiscal Year 2026 proposed [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Q+A: Kalderos CEO Angie Franks Talks Truzo, 340B Program Transparency

Kalderos CEO Angie Franks recently spoke with 340B Report about the current battle over 340B rebate models, among other things.
Health technology company Kalderos has made waves in the 340B world in recent years after emerging as a key player [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Trump’s ‘Most Favored Nation’ Order Could Lower 340B Ceiling Prices, but Key Details Remain Unclear

President Donald Trump's "most favored nation" executive order has unclear effects on the 340B program.
President Donald Trump’s recent executive order directing federal agencies to pursue “most favored nation” (MFN) pricing for prescription drugs could [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

NACHC Raises Concerns About 340B Rebates, Various Stakeholders Meet with Trump Administration on Rebate Guidance

NACHC raised concerns about implementing a 340B rebate model in a June 17 letter sent to CMS Administrator Mehmet Oz and HRSA Administrator Thomas Engels.
A national 340B community health center organization, which has faced criticism for its partnership with a powerful drug industry trade [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

AHA Report: 340B Hospitals Face More Federal Oversight, Fare Better in Audits; HRSA Releases Latest Drugmaker Audit

A new AHA analysis found that 340B hospitals face more federal oversight and routinely see higher rates of compliance in federal audits than drugmakers.
Hospitals that participate in the 340B program face more federal oversight and routinely see higher rates of compliance in federal [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

D.C. Federal District Court Dismisses Hospital Lawsuits Over J&J’s Controversial 340B Audit Requests

A Washington D.C. federal judge this week dismissed lawsuits Oregon Health & Science University and four other hospitals filed against HRSA for authorizing J&J to audit their 340B program records.
A Washington D.C. federal court this week threw out five hospital lawsuits challenging the Health Resources and Services Administration (HRSA) [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Recap of Recent Webinar: Key Issues and What to Expect Next on 340B in Washington, D.C.

340B Report Publisher & CEO Ted Slafsky hosted a June 18 subscriber-only webinar, featuring Sue Veer, Devon Seibert-Bailey and Peggy Tighe.
Although the bulk of recent 340B-related legislative action has occurred in statehouses across the country, 340B advocates and stakeholders are [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live